Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View

 

Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View

2014-11-13 14:42:27| Biotech - Topix.net

Until Merck's product can deliver an optimal cure rate at a cheaper price, it poses no threat to Gilead's Harvoni. Merck's attempt to compete with Gilead in finding a cure for hepatitis C has fallen short .

Tags: view rate rear cure

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

19.05 Atlantic Tropical Weather Outlook 19.05 Eastern North Pacific Tropical Weather Outlook 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 18.05 M&S website and app hit by technical issue 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 18.05 Producers to be paid grid premiums for AngusLink beef scores More »